Short-acting anticholinergic bronchodilation does not increase cardiovascular events in smokers with mild to moderate pulmonary obstruction

Respirology

Volumn 18, Issue 4, 2013, Pages 663-668

  De Jong, Emmy ^a   Van Dijk, Wouter D ^a   Heijdra, Yvonne ^a   Lenders, Jacques W M ^a,b   Van Weel, Chris ^a   Akkermans, Reinier ^a   Schermer, Tjard R J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

bronchodilator; cardiovascular disease; chronic obstructive pulmonary disease; interaction; smoking

Indexed keywords

CHOLINESTERASE INHIBITOR; PLACEBO; SHORT ACTING DRUG;

ADULT; ARTICLE; BRONCHODILATATION; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; FORCED EXPIRATORY VOLUME; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY ANALYSIS; SMOKING; SURVIVAL;

ADULT; BRONCHODILATOR AGENTS; CARDIOVASCULAR DISEASES; CHOLINERGIC ANTAGONISTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84876940224     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12040     Document Type: Article

References (27)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. [Accessed 1 March 2012.] Available from URL: http://www.goldcopd.org. Updated December 2011.
2. Jemal A, Ward E, Hao Y, et al. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005; 294: 1255-1259. (Pubitemid 41352114)
3. Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur. Respir. J. 2006; 27: 397-412. (Pubitemid 43180921)
4. Chatila WM, Thomashow BM, Minai OA, et al. Comorbidities in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2008; 5: 549-555. (Pubitemid 351669185)
5. Curkendall SM, Lanes S, de Luise C, et al. Chronic obstructive pulmonary disease severity and cardiovascular outcomes. Eur. J. Epidemiol. 2006; 21: 803-813. (Pubitemid 44885203)
6. Rodrigo GJ, Castro-Rodriguez JA, Nannini LJ, et al. Tiotropium and risk for fatal and nonfatal cardiovascular events in patients with chronic obstructive pulmonary disease: systematic review with meta-analysis. Respir. Med. 2009; 103: 1421-1429.
7. Celli B, Decramer M, Kesten S, et al. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2009; 180: 948-955.
8. Salpeter SR, Ormiston TM, Salpeter EE,. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest 2004; 125: 2309-2321. (Pubitemid 38796452)
9. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N. Engl. J. Med. 2007; 356: 775-789. (Pubitemid 46294610)
10. Singh S, Loke YK, Enright PL, et al. Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials. BMJ 2011; 342: d3215.
11. Teo KK, Ounpuu S, Hawken S, et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 2006; 368: 647-658. (Pubitemid 44223693)
12. Doll R, Peto R, Boreham J, et al. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004; 328: 1519. doi: 10.1136/bmj.38142.554479.AE
13. Scanlon PD, Connett JE, Waller LA, et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am. J. Respir. Crit. Care Med. 2000; 161: 381-390. (Pubitemid 30129442)
14. Godtfredsen NS, Lam TH, Hansel TT, et al. COPD-related morbidity and mortality after smoking cessation: status of the evidence. Eur. Respir. J. 2008; 32: 844-853.
15. Anthonisen NR, Connett JE, Enright PL, et al. Hospitalizations and mortality in the Lung Health Study. Am. J. Respir. Crit. Care Med. 2002; 166: 333-339. (Pubitemid 34864422)
16. Ellerbeck EF, Mahnken JD, Cupertino AP, et al. Effect of varying levels of disease management on smoking cessation: a randomized trial. Ann. Intern. Med. 2009; 150: 437-446.
17. Schermer T, Heijdra Y, Zadel S, et al. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD. Respir. Med. 2007; 101: 1355-1362. (Pubitemid 46667657)
18. Cazzola M, Matera MG,. Novel long-acting bronchodilators for COPD and asthma. Br. J. Pharmacol. 2008; 155: 291-299.
19. van Dijk WD, Heijdra Y, Scheepers PT, et al. Interaction in COPD experiment (ICE): a hazardous combination of cigarette smoking and bronchodilation in chronic obstructive pulmonary disease. Med. Hypotheses 2010; 74: 277-280.
20. Connett JE, Kusek JW, Bailey WC, et al. Design of the Lung Health Study: a randomized clinical trial of early intervention for chronic obstructive pulmonary disease. Control. Clin. Trials 1993; 14: 3S-19S. (Pubitemid 23102307)
21. Connett JE, Bjornson-Benson WM, Daniels K,. Recruitment of participants in the Lung Health Study, II: assessment of recruiting strategies. Control. Clin. Trials 1993; 14: 38S-51S. (Pubitemid 23102309)
22. Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008; 63: 1046-1051.
23. van Dijk WD, Lenders JW, Holtman J, et al. Bronchodilation and smoking interaction in COPD: a cohort pilot Study to assess cardiovascular risk. Respiration 2012; 83: 125-132.
24. van Dijk WD, Heijdra Y, Lenders JW, et al. Cigarette smoke retention and bronchodilation in patients with COPD. A controlled randomized trial. Respir. Med. 2013; 107: 112-119. doi: 10.1016/j.rmed.2012.09.019.
25. Iso H, Date C, Yamamoto A, et al. Smoking cessation and mortality from cardiovascular disease among Japanese men and women: the JACC Study. Am. J. Epidemiol. 2005; 161: 170-179. (Pubitemid 40096792)
26. Kawachi I, Colditz GA, Stampfer MJ, et al. Smoking cessation in relation to total mortality rates in women. A prospective cohort study. Ann. Intern. Med. 1993; 119: 992-1000. (Pubitemid 23334655)
27. Hozawa A, Ohkubo T, Yamaguchi J, et al. Cigarette smoking and mortality in Japan: the Miyagi Cohort Study. J. Epidemiol. 2004; 14 (Suppl. 1): S12-17. (Pubitemid 41403870)